Hjem › Neuroblastom › Oregon
Neuroblastom kliniske forsøg i Oregon
6 studier for Neuroblastom søger deltagere på steder i Oregon.
Byer i Oregon
Officiel studietekst (engelsk)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
RekruttererFase 3
Op til 30 år · Alle køn · Opdateret 2. okt. 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Oregon Health and Science University ( Site 1004), Portland
RekruttererFase 1/2
6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Randall Children's Hospital, Portland
RekruttererFase 2
Op til 22 år · Alle køn · Opdateret 4. sep. 2026 · NCT02559778Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Randall Children's Hospital, Portland
RekruttererFase 2
Alder 1 til 21 · Alle køn · Opdateret 3. sep. 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Legacy Emanuel Children's Hospital, Portland
RekruttererFase 3
365 Days – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Randall Children's Hospital, Portland
RekruttererFase 2
12 Months – 21 Years · Alle køn · Opdateret 12. aug. 2026 · NCT05489887Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.